Immunofluorescent stainings of PD-1, PD-L1 and myeloid markers.... | Download Scientific Diagram
Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion | Nature Communications
Long-term persistence and functionality of adoptively transferred antigen-specific T cells with genetically ablated PD-1 expression | PNAS
Frontiers | The Role of PD-1 in Acute and Chronic Infection
Coexpression of PD-1, NFB activation, and proliferation marker in... | Download Scientific Diagram
Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation - ScienceDirect
Learning from PD-1 Resistance: New Combination Strategies: Trends in Molecular Medicine
The diverse functions of the PD1 inhibitory pathway | Nature Reviews Immunology
Frontiers | PD-L1 Distribution and Perspective for Cancer Immunotherapy—Blockade, Knockdown, or Inhibition
Biomarkers of response to PD-1 pathway blockade | British Journal of Cancer
PD-1-high TILs: a predictive biomarker for ICB in lung cancer
Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors | Molecular Cancer | Full Text
Raji-hPD-1 cells | ADCC targets | InvivoGen
PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity
PD-1 Is a Selective Marker of Human Follicular T Cells (A)... | Download Scientific Diagram
PD-1/PD-L1, What a Powerful Immune Checkpoint-CUSABIO
Mechanistic insight of predictive biomarkers for antitumor PD‑1/PD‑L1 blockade: A paradigm shift towards immunome evaluation (Review)
Cancers | Free Full-Text | Immunotherapy Predictive Molecular Markers in Advanced Gastroesophageal Cancer: MSI and Beyond
Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups | Nature Immunology
Immune checkpoint blockade in HIV - eBioMedicine
Predictive Markers for the Efficacy of Anti–PD-1/PD-L1 Antibodies in Lung Cancer - ScienceDirect
Mechanistic insight of predictive biomarkers for antitumor PD‑1/PD‑L1 blockade: A paradigm shift towards immunome evaluation (Review)
Anti-PDL-1 Antibody Treatment Reduces Expression of the Exhaustion Marker PD -1 in T Cells | Biocompare Antibody Review
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies | Nature Immunology
Predictive biomarkers in PD-1/PD-L1 checkpoint blockade immunotherapy - ScienceDirect
Frontiers | Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors
